Table 5.
Per-protocol analysis
| Parameter | Placebo Arm
|
Niacinamide Arm
|
||||
|---|---|---|---|---|---|---|
| Week 1 | Week 9 | P | Week 1 | Week 9 | P | |
| Phosphorus (mg/dl) | 5.59 ± 1.53 | 5.96 ± 1.54 | NS | 6.45 ± 1.33 | 5.28 ± 1.22 | 0.002 |
| Calcium (mg/dl) | 9.41 ± 0.58 | 9.60 ± 0.73 | NS | 9.47 ± 0.71 | 9.58 ± 0.64 | NS |
| Calcium-phosphorus product (mg2/dl2) | 52.47 ± 14.26 | 57.02 ± 14.88 | NS | 61.00 ± 12.88 | 50.54 ± 11.46 | 0.003 |
| iPTH (pg/ml) | 296 ± 182 | 277 ± 219 | NS | 305 ± 254 | 311 ± 194 | NS |
| Uric acid (mg/dl) | 6.95 ± 1.77 | 6.67 ± 1.67 | NS | 7.01 ± 1.67 | 6.70 ± 1.56 | NS |
| Total cholesterol (mg/dl) | 139 ± 29 | 134 ± 27 | NS | 137 ± 27 | 143 ± 26 | NS |
| LDL (mg/dl) | 56 ± 21 | 54 ± 28 | NS | 58 ± 27 | 55 ± 22 | NS |
| HDL (mg/dl) | 52 ± 17 | 50 ± 17 | NS | 49 ± 16 | 58 ± 20 | 0.070 |
| TG (mg/dl) | 153 ± 73 | 148 ± 80 | NS | 150 ± 73 | 157 ± 84 | NS |
| Platelet (1000/mm3) | 214 ± 72 | 224 ± 59 | NS | 214 ± 52 | 197 ± 56 | NS |